News

Use of GLP-1s, especially semaglutide and liraglutide, may increase risk for nonarteritic anterior ischemic optic neuropathy ...
Samuel Blake, also known professionally as Sam Blake or Samuel Stewart Blake, is pioneering two rapidly growing ventures that ...
When people were randomised to receive either a placebo or Ozempic, they became biologically younger with the latter drug ...
GLP-1 medications like semaglutide and tirzepatide are helping people shed weight and keep it off. But let’s be clear: These aren’t miracle pills you buy off ...
Biotechs investigate mitochondria-targeting drugs to claim a share in the weight loss drug market dominated by GLP-1RAs.
Researchers conducted the SOUL clinical trial to assess the effect of oral semaglutide on cardiovascular outcomes across different HbA1c and BMI statuses in type 2 diabetes.
Several new weight loss drugs are undergoing trials in the UK. These drugs will work similarly to those already available but ...
Demand for drugs, including weight-loss injections, is sending people to dangerous places to get their medicine. But spotting ...
Entrepreneurship raises your risk of obesity, but small changes to your diet can have similar affects to new weight-loss ...
Indian pharma is hoping to cash in. Generic firms, such as Biocon, are already offering weight-loss drugs, such as cheaper ...
Aggressive social media marketing by influencers has fuelled a surge in over-the-counter use of the diabetes and obesity ...
TAMPA, FL / ACCESS Newswire / July 29, 2025 / The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, ...